Arrowstreet Capital’s ViewRay, Inc. VRAY Stock Holding History

Arrowstreet Capital’s Portfolio VRAY Stock Details VRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,700	Closed	-$117K	–	1387
2017 Q1	$117K	Buy	+13,700	New	+$74.7K	﹤0.01%	1223

Other funds holding VRAY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital's VRAY Position: Q2 2017 in Review

Arrowstreet Capital sold out of ViewRay, Inc. (VRAY) in Q2 2017, closing a stake of 13,700 shares — an estimated $117K sold.

Arrowstreet Capital first reported a position in VRAY in Q1 2017 and held it in 1 quarter. The position peaked at $117K in Q1 2017. 68 funds tracked by Wall St. Rank hold VRAY as of Q2 2017.

Arrowstreet Capital reported no remaining ViewRay, Inc. position as of Q2 2017 after selling out during the quarter.
Arrowstreet Capital sold 13,700 ViewRay, Inc. shares in Q2 2017, an estimated $117K.
Arrowstreet Capital first reported a position in ViewRay, Inc. in Q1 2017 and held it in 1 quarter.
Arrowstreet Capital's ViewRay, Inc. position peaked at $117K in Q1 2017.
68 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q2 2017.

Based on Arrowstreet Capital's 13F filing for Q2 2017, filed 15 Aug 2017.